TEST BANK
NEONATAL & PEDIATRIC RESPIRATORY CARE
5TH EDITION, WALSH
TEST BANK
NEONATAL AND PEDIATRIC RESPIRATORY CARE, 5TH EDITION, BRIAN K. WALSH TEST BANK
TABLE OF CONTENTS
CHAPTER 1. FETAL LUNG DEVELOPMENT
CHAPTER 2. FETAL GAS EXCHANGE AND CIRCULATION
CHAPTER 3. ANTENATAL ASSESSMENT AND HIGH-RISK DELIVERY
CHAPTER 4. EXAMINATION AND ASSESSMENT OF THE NEONATAL AND PEDIATRIC PATIENT
CHAPTER 5. PULMONARY FUNCTION TESTING AND BEDSIDE PULMONARY MECHANICS
CHAPTER 6. RADIOGRAPHIC ASSESSMENT
CHAPTER 7. PEDIATRIC FLEXIBLE BRONCHOSCOPY
CHAPTER 8. INVASIVE BLOOD GAS ANALYSIS AND CARDIOVASCULAR MONITORING
CHAPTER 9. NONINVASIVE MONITORING IN NEONATAL AND PEDIATRIC CARE
CHAPTER 10. OXYGEN ADMINISTRATION
CHAPTER 11. AEROSOLS AND ADMINISTRATION OF INHALED MEDICATIONS
CHAPTER 12. AIRWAY CLEARANCE TECHNIQUES AND HYPERINFLATION THERAPY
CHAPTER 13. AIRWAY MANAGEMENT
CHAPTER 14. SURFACTANT REPLACEMENT THERAPY
CHAPTER 15. NONINVASIVE MECHANICAL VENTILATION AND CONTINUOUS POSITIVE PRESSURE OF THE
NEONATE
CHAPTER 16. NONINVASIVE MECHANICAL VENTILATION OF THE INFANT AND CHILD
,CHAPTER 17. INVASIVE MECHANICAL VENTILATION OF THE NEONATE AND PEDIATRIC PATIENT
CHAPTER 18. ADMINISTRATION OF GAS MIXTURES
CHAPTER 19. EXTRACORPOREAL MEMBRANE OXYGENATION
CHAPTER 20. PHARMACOLOGY
CHAPTER 21. THORACIC ORGAN TRCORRECT ANSWERPLANTATION
CHAPTER 22. NEONATAL PULMONARY DISORDERS
CHAPTER 23. SURGICAL DISORDERS IN CHILDHOOD THAT AFFECT RESPIRATORY CARE
CHAPTER 24. CONGENITAL CARDIAC DEFECTS
CHAPTER 25. PEDIATRIC SLEEP-DISORDERED BREATHING
CHAPTER 26. PEDIATRIC AIRWAY DISORDERS AND PARENCHYMAL LUNG DISEASES
CHAPTER 27. ASTHMA
CHAPTER 28. CYSTIC FIBROSIS
CHAPTER 29. ACUTE RESPIRATORY DISTRESS SYNDROME
CHAPTER 30. SHOCK
CHAPTER 31. PEDIATRIC TRAUMA
CHAPTER 32. DISORDERS OF THE PLEURA
CHAPTER 33. NEUROLOGICAL AND NEUROMUSCULAR DISORDERS
CHAPTER 34. PEDIATRIC EMERGENCIES
CHAPTER 35. HOME CARE OF THE POSTPARTUM FAMILY
CHAPTER 36. QUALITY AND SAFETY
CHAPTER 1: FETAL LUNG DEVELOPMENT
WALSH: NEONATAL & PEDIATRIC RESPIRATORY CARE 5TH EDITION TEST BANK (2020)
MULTIPLE CHOICE
1. WHICH OF THE FOLLOWING PHASES OF HUMAN LUNG DEVELOPMENT IS CHARACTERIZED BY
THE FORMATION OF A CAPILLARY NETWORK AROUND AIRWAY PASSAGES?
,A. PSEUDOGLANDULAR
B. SACCULAR
C. ALVEOLAR
D. CANALICULAR
CORRECT ANSWER: D
THE CANALICULAR PHASE FOLLOWS THE PSEUDOGLANDULAR PHASE, LASTING FROM APPROXIMATELY
17 WEEKS TO 26 WEEKS OF GESTATION. THIS PHASE IS SO NAMED BECAUSE OF THE APPEARANCE OF
VASCULAR CHANNELS, OR CAPILLARIES, WHICH BEGIN TO GROW BY FORMING A CAPILLARY NETWORK
AROUND THE AIR PASSAGES. DURING THE PSEUDOGLANDULAR STAGE, WHICH BEGINS AT DAY 52 AND
EXTENDS TO WEEK 16 OF GESTATION, THE AIRWAY SYSTEM SUBDIVIDES EXTENSIVELY AND THE
CONDUCTING AIRWAY SYSTEM DEVELOPS, ENDING WITH THE TERMINAL BRONCHIOLES. THE SACCULAR
STAGE OF DEVELOPMENT, WHICH TAKES PLACE FROM WEEKS 29 TO 36 OF GESTATION, IS
CHARACTERIZED BY THE DEVELOPMENT OF SACS THAT LATER BECOME ALVEOLI. DURING THE
SACCULAR PHASE, A TREMENDOUS INCREASE IN THE POTENTIAL GAS- EXCHANGING SURFACE AREA
OCCURS. THE DISTINCTION BETWEEN THE SACCULAR STAGE AND THE ALVEOLAR STAGE IS ARBITRARY.
THE ALVEOLAR STAGE STRETCHES FROM 39 WEEKS OF GESTATION TO TERM. THIS STAGE IS
REPRESENTED BY THE ESTABLISHMENT OF ALVEOLI.
REF: PP. 3-5
2. REGARDING POSTNATAL LUNG GROWTH, BY APPROXIMATELY WHAT AGE DO MOST OF THE
ALVEOLI THAT WILL BE PRESENT IN THE LUNGS FOR LIFE DEVELOP?
A. 6 MONTHS
B. 1 YEAR
C. 1.5 YEARS
D. 2 YEARS
CORRECT ANSWER: C
MOST OF THE POSTNATAL FORMATION OF ALVEOLI IN THE INFANT OCCURS OVER THE FIRST 1.5 YEARS
OF LIFE. AT 2 YEARS OF AGE, THE NUMBER OF ALVEOLI VARIES SUBSTANTIALLY AMONG INDIVIDUALS.
AFTER 2 YEARS OF AGE, MALES HAVE MORE ALVEOLI THAN DO FEMALES. AFTER ALVEOLAR
MULTIPLICATION ENDS, THE ALVEOLI CONTINUE TO INCREASE IN SIZE UNTIL THORACIC GROWTH IS
COMPLETED.
REF: P. 6
, 3. THE RESPIRATORY THERAPIST IS EVALUATING A NEWBORN WITH MILD RESPIRATORY DISTRESS
DUE TO TRACHEAL STENOSIS. DURING WHICH PERIOD OF LUNG DEVELOPMENT DID THIS PROBLEM
DEVELOP?
A. EMBRYONAL
B. SACCULAR
C. CANALICULAR
D. ALVEOLAR
CORRECT ANSWER: A
THE INITIAL STRUCTURES OF THE PULMONARY TREE DEVELOP DURING THE EMBRYONAL STAGE.
ERRORS IN DEVELOPMENT DURING THIS TIME MAY RESULT IN LARYNGEAL, TRACHEAL, OR ESOPHAGEAL
ATRESIA OR STENOSIS. PULMONARY HYPOPLASIA, AN INCOMPLETE DEVELOPMENT OF THE LUNGS
CHARACTERIZED BY AN ABNORMALLY LOW NUMBER AND/OR SIZE OF BRONCHOPULMONARY
SEGMENTS AND/OR ALVEOLI, CAN DEVELOP DURING THE PSEUDOGLANDULAR PHASE. IF THE FETUS IS
BORN DURING THE CANALICULAR PHASE (I.E., PREMATURELY), SEVERE RESPIRATORY DISTRESS CAN BE
EXPECTED BECAUSE THE INADEQUATELY DEVELOPED AIRWAYS, ALONG WITH INSUFFICIENT AND
IMMATURE SURFACTANT PRODUCTION BY ALVEOLAR TYPE II CELLS, GIVES RISE TO THE CONSTELLATION
OF PROBLEMS KNOWN AS INFANT RESPIRATORY DISTRESS SYNDROME.
REF: P. 6
4. WHICH OF THE FOLLOWING MECHANISMS IS (ARE) RESPONSIBLE FOR THE POSSIBLE
ASSOCIATION BETWEEN OLIGOHYDRAMNIOS AND LUNG HYPOPLASIA?
I. ABNORMAL CARBOHYDRATE METABOLISM
II. MECHANICAL RESTRICTION OF THE CHEST WALL
III. INTERFERENCE WITH FETAL BREATHING
IV. FAILURE TO PRODUCE FETAL LUNG LIQUID
A. I AND III ONLY
B. II AND III ONLY
C. I, II, AND IV ONLY
D. II, III, AND IV ONLY
NEONATAL & PEDIATRIC RESPIRATORY CARE
5TH EDITION, WALSH
TEST BANK
NEONATAL AND PEDIATRIC RESPIRATORY CARE, 5TH EDITION, BRIAN K. WALSH TEST BANK
TABLE OF CONTENTS
CHAPTER 1. FETAL LUNG DEVELOPMENT
CHAPTER 2. FETAL GAS EXCHANGE AND CIRCULATION
CHAPTER 3. ANTENATAL ASSESSMENT AND HIGH-RISK DELIVERY
CHAPTER 4. EXAMINATION AND ASSESSMENT OF THE NEONATAL AND PEDIATRIC PATIENT
CHAPTER 5. PULMONARY FUNCTION TESTING AND BEDSIDE PULMONARY MECHANICS
CHAPTER 6. RADIOGRAPHIC ASSESSMENT
CHAPTER 7. PEDIATRIC FLEXIBLE BRONCHOSCOPY
CHAPTER 8. INVASIVE BLOOD GAS ANALYSIS AND CARDIOVASCULAR MONITORING
CHAPTER 9. NONINVASIVE MONITORING IN NEONATAL AND PEDIATRIC CARE
CHAPTER 10. OXYGEN ADMINISTRATION
CHAPTER 11. AEROSOLS AND ADMINISTRATION OF INHALED MEDICATIONS
CHAPTER 12. AIRWAY CLEARANCE TECHNIQUES AND HYPERINFLATION THERAPY
CHAPTER 13. AIRWAY MANAGEMENT
CHAPTER 14. SURFACTANT REPLACEMENT THERAPY
CHAPTER 15. NONINVASIVE MECHANICAL VENTILATION AND CONTINUOUS POSITIVE PRESSURE OF THE
NEONATE
CHAPTER 16. NONINVASIVE MECHANICAL VENTILATION OF THE INFANT AND CHILD
,CHAPTER 17. INVASIVE MECHANICAL VENTILATION OF THE NEONATE AND PEDIATRIC PATIENT
CHAPTER 18. ADMINISTRATION OF GAS MIXTURES
CHAPTER 19. EXTRACORPOREAL MEMBRANE OXYGENATION
CHAPTER 20. PHARMACOLOGY
CHAPTER 21. THORACIC ORGAN TRCORRECT ANSWERPLANTATION
CHAPTER 22. NEONATAL PULMONARY DISORDERS
CHAPTER 23. SURGICAL DISORDERS IN CHILDHOOD THAT AFFECT RESPIRATORY CARE
CHAPTER 24. CONGENITAL CARDIAC DEFECTS
CHAPTER 25. PEDIATRIC SLEEP-DISORDERED BREATHING
CHAPTER 26. PEDIATRIC AIRWAY DISORDERS AND PARENCHYMAL LUNG DISEASES
CHAPTER 27. ASTHMA
CHAPTER 28. CYSTIC FIBROSIS
CHAPTER 29. ACUTE RESPIRATORY DISTRESS SYNDROME
CHAPTER 30. SHOCK
CHAPTER 31. PEDIATRIC TRAUMA
CHAPTER 32. DISORDERS OF THE PLEURA
CHAPTER 33. NEUROLOGICAL AND NEUROMUSCULAR DISORDERS
CHAPTER 34. PEDIATRIC EMERGENCIES
CHAPTER 35. HOME CARE OF THE POSTPARTUM FAMILY
CHAPTER 36. QUALITY AND SAFETY
CHAPTER 1: FETAL LUNG DEVELOPMENT
WALSH: NEONATAL & PEDIATRIC RESPIRATORY CARE 5TH EDITION TEST BANK (2020)
MULTIPLE CHOICE
1. WHICH OF THE FOLLOWING PHASES OF HUMAN LUNG DEVELOPMENT IS CHARACTERIZED BY
THE FORMATION OF A CAPILLARY NETWORK AROUND AIRWAY PASSAGES?
,A. PSEUDOGLANDULAR
B. SACCULAR
C. ALVEOLAR
D. CANALICULAR
CORRECT ANSWER: D
THE CANALICULAR PHASE FOLLOWS THE PSEUDOGLANDULAR PHASE, LASTING FROM APPROXIMATELY
17 WEEKS TO 26 WEEKS OF GESTATION. THIS PHASE IS SO NAMED BECAUSE OF THE APPEARANCE OF
VASCULAR CHANNELS, OR CAPILLARIES, WHICH BEGIN TO GROW BY FORMING A CAPILLARY NETWORK
AROUND THE AIR PASSAGES. DURING THE PSEUDOGLANDULAR STAGE, WHICH BEGINS AT DAY 52 AND
EXTENDS TO WEEK 16 OF GESTATION, THE AIRWAY SYSTEM SUBDIVIDES EXTENSIVELY AND THE
CONDUCTING AIRWAY SYSTEM DEVELOPS, ENDING WITH THE TERMINAL BRONCHIOLES. THE SACCULAR
STAGE OF DEVELOPMENT, WHICH TAKES PLACE FROM WEEKS 29 TO 36 OF GESTATION, IS
CHARACTERIZED BY THE DEVELOPMENT OF SACS THAT LATER BECOME ALVEOLI. DURING THE
SACCULAR PHASE, A TREMENDOUS INCREASE IN THE POTENTIAL GAS- EXCHANGING SURFACE AREA
OCCURS. THE DISTINCTION BETWEEN THE SACCULAR STAGE AND THE ALVEOLAR STAGE IS ARBITRARY.
THE ALVEOLAR STAGE STRETCHES FROM 39 WEEKS OF GESTATION TO TERM. THIS STAGE IS
REPRESENTED BY THE ESTABLISHMENT OF ALVEOLI.
REF: PP. 3-5
2. REGARDING POSTNATAL LUNG GROWTH, BY APPROXIMATELY WHAT AGE DO MOST OF THE
ALVEOLI THAT WILL BE PRESENT IN THE LUNGS FOR LIFE DEVELOP?
A. 6 MONTHS
B. 1 YEAR
C. 1.5 YEARS
D. 2 YEARS
CORRECT ANSWER: C
MOST OF THE POSTNATAL FORMATION OF ALVEOLI IN THE INFANT OCCURS OVER THE FIRST 1.5 YEARS
OF LIFE. AT 2 YEARS OF AGE, THE NUMBER OF ALVEOLI VARIES SUBSTANTIALLY AMONG INDIVIDUALS.
AFTER 2 YEARS OF AGE, MALES HAVE MORE ALVEOLI THAN DO FEMALES. AFTER ALVEOLAR
MULTIPLICATION ENDS, THE ALVEOLI CONTINUE TO INCREASE IN SIZE UNTIL THORACIC GROWTH IS
COMPLETED.
REF: P. 6
, 3. THE RESPIRATORY THERAPIST IS EVALUATING A NEWBORN WITH MILD RESPIRATORY DISTRESS
DUE TO TRACHEAL STENOSIS. DURING WHICH PERIOD OF LUNG DEVELOPMENT DID THIS PROBLEM
DEVELOP?
A. EMBRYONAL
B. SACCULAR
C. CANALICULAR
D. ALVEOLAR
CORRECT ANSWER: A
THE INITIAL STRUCTURES OF THE PULMONARY TREE DEVELOP DURING THE EMBRYONAL STAGE.
ERRORS IN DEVELOPMENT DURING THIS TIME MAY RESULT IN LARYNGEAL, TRACHEAL, OR ESOPHAGEAL
ATRESIA OR STENOSIS. PULMONARY HYPOPLASIA, AN INCOMPLETE DEVELOPMENT OF THE LUNGS
CHARACTERIZED BY AN ABNORMALLY LOW NUMBER AND/OR SIZE OF BRONCHOPULMONARY
SEGMENTS AND/OR ALVEOLI, CAN DEVELOP DURING THE PSEUDOGLANDULAR PHASE. IF THE FETUS IS
BORN DURING THE CANALICULAR PHASE (I.E., PREMATURELY), SEVERE RESPIRATORY DISTRESS CAN BE
EXPECTED BECAUSE THE INADEQUATELY DEVELOPED AIRWAYS, ALONG WITH INSUFFICIENT AND
IMMATURE SURFACTANT PRODUCTION BY ALVEOLAR TYPE II CELLS, GIVES RISE TO THE CONSTELLATION
OF PROBLEMS KNOWN AS INFANT RESPIRATORY DISTRESS SYNDROME.
REF: P. 6
4. WHICH OF THE FOLLOWING MECHANISMS IS (ARE) RESPONSIBLE FOR THE POSSIBLE
ASSOCIATION BETWEEN OLIGOHYDRAMNIOS AND LUNG HYPOPLASIA?
I. ABNORMAL CARBOHYDRATE METABOLISM
II. MECHANICAL RESTRICTION OF THE CHEST WALL
III. INTERFERENCE WITH FETAL BREATHING
IV. FAILURE TO PRODUCE FETAL LUNG LIQUID
A. I AND III ONLY
B. II AND III ONLY
C. I, II, AND IV ONLY
D. II, III, AND IV ONLY
